{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:12:10Z","timestamp":1768907530554,"version":"3.49.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,25]]},"DOI":"10.1182\/bloodadvances.2017005090","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:40:32Z","timestamp":1493167232000},"page":"703-706","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Blood volume\u2013based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease"],"prefix":"10.1182","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-5379","authenticated-orcid":false,"given":"Margaret V.","family":"Ragni","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA; and Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"issue":"21","key":"2019111607212348000_B1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111607212348000_B2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607212348000_B3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2516.1999.00342.x","article-title":"von Willebrand disease and bleeding in women","volume":"5","author":"Ragni","year":"1999","journal-title":"Haemophilia"},{"issue":"2","key":"2019111607212348000_B4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2005.01150.x","article-title":"von Willebrand disease and pregnancy","volume":"3","author":"Kujovich","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111607212348000_B5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607212348000_B6","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1111\/hae.12739","article-title":"Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database","volume":"21","author":"Malec","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"2019111607212348000_B7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"4","key":"2019111607212348000_B8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey","volume":"21","author":"Stoof","year":"2015","journal-title":"Haemophilia"},{"issue":"7","key":"2019111607212348000_B9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00001721-200310000-00005","article-title":"Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium","volume":"14","author":"S\u00e1nchez-Luceros","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"11","key":"2019111607212348000_B10","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury-Stewart","year":"2014","journal-title":"PLOS ONE"},{"issue":"2","key":"2019111607212348000_B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2516.2011.02625.x","article-title":"Changes in the levels of factor VIII and von Willebrand factor in the puerperium","volume":"18","author":"Huq","year":"2012","journal-title":"Haemophilia"},{"issue":"2","key":"2019111607212348000_B12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"2019111607212348000_B13","first-page":"117","article-title":"Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus"},{"key":"2019111607212348000_B14","unstructured":"National Hemophilia Foundation. MASAC guidelines for perinatal management of women with bleeding disorders and carriers of hemophilia A and B. NHF Document No. 192. http:\/\/www.hemophilia.org\/Researchers-Healthcare-Providers-and-Scientific-Advisory-Council-MASAC\/MASAC-Recommendations\/MASAC-Guidelines-for-Perinatal-Management-of-Women-with-Bleeding-Disorders-and-Carriers-of-Hemophilia-A-and-B. Accessed 28 January 2017."},{"issue":"4","key":"2019111607212348000_B15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111607212348000_B16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0308-2261(21)00496-3","article-title":"Blood volume changes in normal pregnancy","volume":"14","author":"Hytten","year":"1985","journal-title":"Clin Haematol"},{"issue":"6, pt 1","key":"2019111607212348000_B17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0002-9378(89)90900-9","article-title":"Central hemodynamic assessment of normal term pregnancy","volume":"161","author":"Clark","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111607212348000_B18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cvr\/cvu009","article-title":"Maternal cardiac metabolism in pregnancy","volume":"101","author":"Liu","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2019111607212348000_B19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jcp.35.3.289","article-title":"Effect of height and weight on the in vivo recovery of transfused factor VIII C","volume":"35","author":"Aronstam","year":"1982","journal-title":"J Clin Pathol"},{"issue":"2","key":"2019111607212348000_B20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood-2011-07-360594","article-title":"Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight","volume":"119","author":"Bj\u00f6rkman","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111607212348000_B21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/hae.12300","article-title":"Pharmacokinetic analysis of anti-hemophilic factor in the obese patient","volume":"20","author":"Graham","year":"2014","journal-title":"Haemophilia"},{"issue":"10","key":"2019111607212348000_B22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"2019111607212348000_B23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/138920009788897993","article-title":"Variation of drug kinetics in pregnancy","volume":"10","author":"Pavek","year":"2009","journal-title":"Curr Drug Metab"},{"issue":"3","key":"2019111607212348000_B24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200948030-00002","article-title":"Effect of pregnancy on the pharmacokinetics of antihypertensive drugs","volume":"48","author":"Anderson","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"22","key":"2019111607212348000_B25","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1400.1400","article-title":"Von Willebrand factor to prevent postpartum hemorrhage [abstract]","volume":"128","author":"Machin","year":"2016","journal-title":"Blood"},{"issue":"8943","key":"2019111607212348000_B26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"2019111607212348000_B27","first-page":"236","article-title":"Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study","volume-title":"Thromb Res","author":"Seaman","year":"2016"},{"issue":"11","key":"2019111607212348000_B28","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jth.13142","article-title":"Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register","volume":"13","author":"Seaman","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607212348000_B29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.12194","article-title":"Reduced prevalence of arterial thrombosis in von Willebrand disease","volume":"11","author":"Sanders","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111607212348000_B30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"issue":"17","key":"2019111607212348000_B31","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111607212348000_B32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0030-1255445","article-title":"Structure and function of a recombinant von Willebrand factor drug candidate","volume":"36","author":"Turecek","year":"2010","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/11\/703\/877066\/advances005090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/11\/703\/877066\/advances005090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T22:16:50Z","timestamp":1658960210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/11\/703\/15621\/Blood-volumebased-von-Willebrand-factor-to-prevent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,4,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017005090","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}